4-8601318-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001014447.3(CPZ):c.317C>T(p.Ala106Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000559 in 1,609,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001014447.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPZ | NM_001014447.3 | c.317C>T | p.Ala106Val | missense_variant | 3/11 | ENST00000360986.9 | NP_001014447.2 | |
CPZ | NM_003652.4 | c.284C>T | p.Ala95Val | missense_variant | 2/10 | NP_003643.3 | ||
CPZ | NM_001014448.3 | c.-95C>T | 5_prime_UTR_variant | 3/11 | NP_001014448.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPZ | ENST00000360986.9 | c.317C>T | p.Ala106Val | missense_variant | 3/11 | 1 | NM_001014447.3 | ENSP00000354255.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245852Hom.: 0 AF XY: 0.00000750 AC XY: 1AN XY: 133386
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1457026Hom.: 0 Cov.: 36 AF XY: 0.00000276 AC XY: 2AN XY: 724162
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.317C>T (p.A106V) alteration is located in exon 3 (coding exon 3) of the CPZ gene. This alteration results from a C to T substitution at nucleotide position 317, causing the alanine (A) at amino acid position 106 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at